COMMUNIQUÉS West-GlobeNewswire

Poseida Therapeutics Appoints Martin Giedlin, Ph.D., as Vice President, Technical Operations

05/02/2018 - 14:00

SAN DIEGO, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc. (“Poseida”), a San Diego-based company translating best-in-class gene engineering technologies into lifesaving cell therapies, today announced that [...]

Sorrento’s and Yuhan’s Joint Venture, ImmuneOncia, receives Approval to begin clinical trial of Anti-PD-L1 Monoclonal Antibody in South Korea

05/02/2018 - 14:00

SEOUL, South Korea and SAN DIEGO, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Effective February 5th, 2018, Yuhan Corporation (KRX:000100.KS) (Yuhan) and Sorrento Therapeutics, Inc. (Nasdaq: SRNE ) (Sorrento) announce that the [...]

PositiveID’s Chief Science Officer Discusses Company’s Detection of Flu Virus on its FireflyDX Prototype in Interview with CEOLIVE.TV

05/02/2018 - 14:00

DELRAY BEACH, Fla., Feb. 05, 2018 (GLOBE NEWSWIRE) -- PositiveID Corporation (the “Company”) (OTC:PSID), a life sciences company focused on detection and diagnostics, and its ExcitePCR subsidiary announced today that [...]

Radient Technologies Inc. Announces Approval and Receipt of Controlled Drugs and Substances Licence from Health Canada

05/02/2018 - 14:00

EDMONTON, Alberta, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) (TSX-V: RTI ) is pleased to announce that its application for the Controlled Drugs and Substances Licence has [...]

RavenQuest Asked to Be a Primary Resource for Assembly of First Nations in Saskatchewan

05/02/2018 - 14:00

VANCOUVER, British Columbia, Feb. 05, 2018 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE:RQB) is proud to announce that it will be working with First Nation communities from across [...]

AMAG Pharmaceuticals Announces FDA Approval of Supplemental New Drug Application (sNDA) for Feraheme® (ferumoxytol injection)

05/02/2018 - 14:00

WALTHAM, Mass., Feb. 05, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG ) today announced that the U.S. Food and Drug Administration (FDA) has approved its application to broaden the existing label [...]

ATW Tech Octroie de Nouvelles Options D’achat D’actions

05/02/2018 - 13:53

MONTREAL, 05 févr. 2018 (GLOBE NEWSWIRE) -- ATW Tech (« AtmanCo Inc. » ou la « Société ») (TSX-V: ATW ) annonce qu’aux termes de son régime d’options d’achat d’actions (le « régime »), un total de 2 387 000 options d’ [...]

Appointment of Chairman

05/02/2018 - 11:00

MELBOURNE, Australia, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ: GENE ) (“Company”, “GTG”), is pleased to announce that the Board of Directors has appointed Dr Paul A. Kasian as [...]

Immunicum AB (publ) Presents Case Study of One Patient from Phase I/II HCC Trial at Cholangiocarcinoma Foundation Annual Conference

05/02/2018 - 08:01

Press Release 5 February 2018 Immunicum AB (publ) Presents Case Study of One Patient from Phase I/II HCC Trial at Cholangiocarcinoma Foundation Annual Conference Immunicum AB (publ; IMMU.ST) a biopharmaceutical company [...]

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

05/02/2018 - 07:11

REGULATED INFORMATION GHENT, Belgium, 5 February 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

05/02/2018 - 07:01

REGULATED INFORMATION GHENT, Belgium, 5 February 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]

Addex Provides Key Financial Indicators and Trading Update

05/02/2018 - 07:01

Cash position of CHF6.5 million as of 31 January 2018 Geneva, Switzerland, 5 February 2018 - Addex Therapeutics (SIX: ADXN), a leading company pioneering allosteric modulation-based drug discovery and development, [...]

Aspri Pharma Canada Inc. Announces Acquisition of Subordinate Voting Shares of Devonian Health Group Inc.

03/02/2018 - 00:36

CONCORD, Ontario, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Aspri Pharma Canada Inc. (“ Aspri ), a pharmaceutical products wholesale and manufacturer corporation, announces that on February 1, 2018, Devonian Health Group Inc [...]

Emerald Health Files Second Amended and Restated Final Base Shelf Prospectus

02/02/2018 - 22:41

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS. VICTORIA, British Columbia, Feb. [...]

Flexion Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

02/02/2018 - 22:30

BURLINGTON, Mass., Feb. 02, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq: FLXN ) today announced a grant of inducement stock options to six new employees for an aggregate of 38,800 shares of common stock [...]

Dynavax Technologies Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

02/02/2018 - 22:30

BERKELEY, Calif., Feb. 02, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX ) today announced that on February 1, 2018 the Compensation Committee of Dynavax’s Board of Directors approved the grant [...]

Prothena Announces Departure of Chief Medical Officer

02/02/2018 - 22:15

DUBLIN, Ireland, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ: PRTA ), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein [...]

Keryx Biopharmaceuticals to Host Conference Call of Fourth Quarter and Full Year 2017 Financial Results on Wednesday, February 7, 2018

02/02/2018 - 22:05

BOSTON, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today announced that it will [...]

Digirad Announces Closing of Sale of its MDSS Service Contracts to Philips North America

02/02/2018 - 22:05

SUWANEE, Ga., Feb. 02, 2018 (GLOBE NEWSWIRE) -- Digirad Corporation (Nasdaq: DRAD ) today announced that it had closed its previously announced definitive purchase agreement with Philips North America (“Philips”) to [...]